CASP3基因一个新的功能性SNP rs72689236与川崎病相关性的Meta分析

doi:10.7499/j.issn.1008-8830.2013.06.019

Abstract
Figure/Table
References(26)
Related Citation (15)
Read Tracking
Download Tracking

Download: PDF (1445 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Abstract OBJECTIVE: To investigate the association of rs72689236, a new functional single nucleotide polymorphism (SNP) of the gene encoding caspase-3 (CASP3), with the occurrence and development of Kawasaki disease by a meta analysis. METHODS: A literature search was performed using databases at home and abroad according to inclusion and exclusion criteria, to acquire studies on the relationship between rs72689236 and Kawasaki disease published up to November 2012, including casecontrol studies and transmission disequilibrium tests. An integrated meta analysis was performed using RevMan 5.1 software after the studies were screened and evaluated. RESULTS: Six studies were extracted for systematic review of the association between rs72689236 and Kawasaki disease. The frequency of allele A of the SNP was significantly higher in patients with Kawasaki disease than in the controls (OR=1.34, 95%CI=1.24-1.46, P<0.001); the risk for Kawasaki disease in children with allele A (AA+AG) increased by approximately 44% compared with children with GG (OR=1.44, 95%CI=1.27-1.65, P<0.001). The frequency of allele A of the SNP was significantly higher in Kawasaki disease patients with coronary artery lesions than in those without coronary artery lesions (OR=1.51, 95%CI=1.10-2.07, P= 0.01); the risk for coronary artery lesions in Kawasaki disease patients with allele A (AA+AG) increased by approximately 59% compared with Kawasaki disease patients with GG (OR=1.59, 95%CI= 1.00-2.53, P=0.05］. No association between this SNP and the therapeutic effect of intravenous immunoglobulin (IVIG) was found in patients with Kawasaki disease. CONCLUSIONS: The allele A of functional SNP rs72689236 of CASP3 increases the risk for Kawasaki disease, and it may be used as the genetic marker for susceptibility to coronary artery lesions as a complication of Kawasaki disease. Currently, there is still no sufficient evidence that this SNP has an impact on the therapeutic effect of IVIG in patients with Kawasaki disease, and more studies are needed to investigate the feasibility of its application in individualized treatment.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	PENG Qian
	CHEN Chang-Hui
	WU Qing
	YANG Yuan

Key words： Kawasaki disease Coronary artery lesion Intravenous immunoglobulin CASP3 Meta analysis

Cite this article:

PENG Qian,CHEN Chang-Hui,WU Qing et al. Association of new functional SNP rs72689236 of CASP3 with Kawasaki disease: a meta-analysis[J]. CJCP, 2013, 15(6): 477-483.

URL:

http://www.zgddek.com/EN/10.7499/j.issn.1008-8830.2013.06.019 OR http://www.zgddek.com/EN/Y2013/V15/I6/477

	［1］Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association［J］. Pediatrics, 2004, 114 (6): 1708-1733.
	［2］Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children［J］. Arerugi, 1967, 16 (3):178-222.
	［3］Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients［J］. Circulation, 1996, 94 (6): 1379-1385.
	［4］Onouchi Y. Molecular genetics of Kawasaki disease［J］. Pediatr Res, 2009, 65 (5 Pt 2): 46R-54R.
	［5］Onouchi Y, Ozaki K, Buns JC, Shimizu C, Hamada H, Honda T, et al. Common variants in CASP3 confer susceptibility to Kawasaki disease［J］. Hum Mol Genet, 2010, 19 (14): 2898-2906.
	［6］Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms［J］. Nature Genet, 2008, 40 (1): 35-42.
	［7］The Japan Kawasaki Disease Research Committee. Diagnostic Guidelines Of Kawasaki Disease (5th Revised Edition)［DB/OL］. ［2002-02］. http://www.kawasakidisease.org/diagnostic/index.html.
	［8］Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease［J］. Pediatrics, 2000, 105 (6): e78.
	［9］Horwitz RI, Feinstein AR. Methodologic standards and contradictory results in case-control research［J］. Am J Med, 1979, 66 (4): 556-564.
	［10］Centre for Evidence-based Medicine. Systematic Review (critical appraisal sheet)［DB/OL］. ［2005］. http://www.cebm.net.
	［11］Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease［J］. Nat Genet, 2003, 33 (2): 177-182.
	［12］Gong YG, Wu CN, Xing QH, Zhao XZ, Zhu J, He L. A two-method meta-analysis of Neuregulin 1 (NRG1) association and heterogeneity in schizophrenia［J］. Schizophr Res, 2009, 111 (1-3): 109-114.
	［13］Kuo HC,Yu HR,Juo SH, Yang KD, Wang YS, Liang CD, et al. CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children［J］. J Hum Genet, 2011,56 (2): 161-165.
	［14］Onouchi Y, Suzuki Y, Suzuki H, Terai M, Yasukawa K, Hamada H, et al. ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease［J］. Pharmacogenomics J, 2013, 13(1): 52-59.
	［15］彭茜, 陈昌辉, 吴青, 李波, 廖静, 罗彩丹，等. CASP3基因单核苷酸多态性与中国儿童川崎病的相关性研究［J］. 中华医学遗传学杂志, 2013, 30(2): 180-184.
	［16］Hata A, Onouchi Y. Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine［J］. J Hum Genet, 2009, 54 (2): 67-73.
	［17］Wang CL, Wu YT, Liu CA, Kuo HC, Yang KD. Kawasaki disease: infection, immunity and genetics［J］. Pediatr Infect Dis J, 2005, 24 (11): 998-1004.
	［18］Cheung YF, Huang GY, Chen SB, Liu XQ, Xi L, Liang XC, et al. Inflammatory gene polymorphisms and susceptibility to kawasaki disease and its arterial sequelae［J］. Pediatrics, 2008, 122 (3): e608-e614.
	［19］Lin YJ, Wan L, Wu JY, Sheu JJ, Lin CW, Lan YC, et al. HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms［J］. Arthritis Rheum, 2009, 60 (2): 604-610.
	［20］高天霁. 姑表兄弟同患川崎病2例报道［J］. 中国当代儿科杂志, 2012, 14(4): 314-315.
	［21］Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease［J］. Nat Genet, 2011, 43 (12): 1241-1246.
	［22］Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H, et al. A genome-wide association study identifies three new risk loci for Kawasaki disease［J］. Nat Genet, 2012, 44 (5): 517-521.
	［23］Lee YC, Kuo HC, Chang JS, Chang LY, Huang LM, Chen MR, et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis［J］. Nat Genet, 2012, 44 (5): 522-525.
	［24］Burgner D, Davila S, Breunis WB, Ng SB, Li Y, Bonnard C, et al. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease［J］. PLoS Genet, 2009, 5(1): e1000319.
	［25］Kim JJ, Hong YM, Sohn S, Jang GY, Ha KS, Yun SW, et al. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease［J］. Hum Genet, 2011, 129(5): 487-495.
	［26］Tsai FJ, Lee YC, Chang JS, Huang LM, Huang FY, Chiu NC, et al. Identification of novel susceptibility Loci for kawasaki disease in a Han chinese population by a genome-wide association study［J］. PLoS One, 2011, 6(2): e16853.